Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC411 in sickle cell disease
NCT02604368Phase 3Unknown
- Sponsor
- Micelle BioPharma
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of Altemia in sickle cell disease (SCD), sponsored by Micelle BioPharma. Status: unknown.
02
Drugs
Altemia
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02604368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604368.